Effect of nasal inflammation and of intranasal anti-inflammatory treatment on bronchial asthma

Respiratory Medicine

Volumn 92, Issue 3, 1998, Pages 547-549

  Mygind, N ^a   Dahl, R ^a   Nielsen, L P ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT;

ANTIGEN PRESENTATION; ARTICLE; ASTHMA; BRONCHUS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INTRANASAL DRUG ADMINISTRATION; LOWER RESPIRATORY TRACT; NOSE; NOSE MUCOSA; PRIORITY JOURNAL; RHINITIS;

EID: 0031976210     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90306-7     Document Type: Article

References (28)

1. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol 1997; 99: S781-S786.
2. Holgate ST. Aetiology and pathogenesis of asthma. In: Kay AB, ed. Allergy and allergic Diseases. Oxford: Blackwell Science, 1997; pp. 1366-1378.
3. Andersen I, Proctor DF. The fate and effects of inhaled materials. In: Proctor DF, Andersen I, eds. The Nose. Upper Airway Physiology and the Environments. Amsterdam: Elsevier Biomedical Press, 1982; pp. 423-455.
4. Swift DL, Proctor DF. Access of air to the respiratory tract. In: Brain DF, Proctor DF, Reid LM, eds. Respiratory Defence Mechanisms. New York: Marcel Dekker, 1977; pp. 63-93.
5. Ferris BJ, Mead J, Opie LH. Partitioning of respiratory flow resistance in man. J Appl Physiol 1964; 19: 653-658.
6. Proctor DF, Andersen I, Lundqvist G. Clearance of inhaled particles from the human nose. Arch Intern Med 1973; 131: 132-136.
7. Holm AF, Fokkens WJ, Godthelp T et al. Effect of 3 months' nasal steroid therapy on T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995; 50: 204-209.
8. James SP. The gastrointestinal mucosal immune system. Dig Dis 1993; 11: 146-156.
9. Howarth PH. Seasonal and perennial allergic rhinitis. In: Kay AB, ed. Allergy and Allergic Diseases. Oxford: Blackwell Science, 1997; pp. 1311-1326.
10. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with antigen. J Allergy Clin Immunol 1992; 89: 611.
11. Tsai J-J, Ho C-Y, Wang S-R. Relationship between nasal resistance and airway hyperreactivity following nasal provocation with Dermatophagoides pteronyssinus in allergic rhinitis. Int Arch Allergy Immunol 1995; 106: 286-290.
12. Nielsen LP, Mygind N, Dahl R. A nasal allergen challenge will markedly increase bronchial responsiveness in pollen allergic asthmatics (in preparation) 1998.
13. Henriksen JM, Wenzel A. Effect of intranasal administration of corticosteroid (budesonide) on nasal obstruction, mouth breathing and asthma. Am Rev Respir Dis 1984; 130: 1014-1018.
14. Reeds CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma symptoms. J Allergy Clin Immunol 1988; 81: 1042-1047.
15. Corren J, Adinoff AD, Irvin CG. Nasal beclomethasone dipropionate prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90: 250-256.
16. Aubier M, Levy J, Clerici C, Neukirch F, Herman D. Different effects of nasal and bronchial glucocorticoid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146: 122-126.
17. Watson WTA, Becker AB, Simons FER. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol 1993; 91: 97-101.
18. Wood RA, Eggleston PA. The effects of intranasal steroids on nasal and pulmonary responses to cat exposure. Am J Respir Crit Care Med 1995; 151: 315-320.
19. Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollen. J Allergy Clin Immunol 1995; 95: 515-523.
20. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation and also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996; 98: 274-282.
21. Nielsen LP, Bjerke T, Christensen MB et al. Eosinophil markers in seasonal rhinitis. Intranasal fluticasone propionate inhibits both local and systemic increase during season. Clin Allergy (in press).
22. Jankowski R. Nasal polyposis and asthma. In: Mygind N, Lildholdt T, eds. Nasal Polyposis. An Inflammatory disease and its Treatment. Copenhagen: Munksgaard, 1997; pp. 112-119.
23. Rachelefsky GS, Goldberg M, Katz RM et al. Sinus disease in children with respiratory allergy. J Allergy Clin Immunol 1978; 61: 310-314.
24. Pedersen B, Dahl R, Lindqvist N, Mygind N. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma. Allergy 1990; 45: 451-456.
25. Pedersen W, Hjuler I, Bisgaard H, Mygind N. Nasal inhalation of budesonide from a spacer in children with perennial rhinitis and asthma. Allergy (in press).
26. Morén F, Newman SP. Aerosol particles and deposition in the airways. In: Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma. Similarities and Differences. Copenhagen: Munksgaard, 1990; pp. 258-265.
27. Pedersen B, Dahl R, Mygind N. Bronchial response to oral and nasal inhalation of terbutaline and histamine. In: Mygind N, Pipkorn U, Dahl R, eds. Rhinitis and Asthma. Similarities and Differences. Copenhagen: Munksgaard, 1990; pp. 266-274.
28. Corren J, Rachelefsky GS. Interrelationship between sinusitis and asthma. Immunol Allergy Clin N Am 1994; 14: 171-183.